Safety and Efficacy Study of Sitaxentan Sodium (Thelin™) in Patients With Pulmonary Arterial Hypertension

Study to Assess Safety and Efficacy of Ambrisentan in Subjects With Pulmonary Arterial Hypertension.

NCT00423748 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Bosentan in Sickle Cell Disease (SCD) Patients With Pulmonary Arterial Hypertension (PAH)

NCT00310830 ·Status: TERMINATED ·Phase: PHASE3

Oral CXA-10 in Pulmonary Arterial Hypertension

NCT04125745 ·Status: TERMINATED ·Phase: PHASE2

Effects of the Combination of Bosentan and Sildenafil Versus Sildenafil Monotherapy on Pulmonary Arterial Hypertension (PAH)

NCT00303459 ·Status: COMPLETED ·Phase: PHASE4

Observation Study of the Medication Switch at Patients Treated With Sitaxentan to a Regime Without Sitaxentan

NCT01281371 ·Status: COMPLETED

PRIMEx - A Study of 2 Doses of Oral CXA-10 in Pulmonary Arterial Hypertension (PAH)

NCT03449524 ·Status: TERMINATED ·Phase: PHASE2

Study Providing Monotherapy (Sitaxsentan) And Combination Therapy (Sitaxsentan+Sildenafil) To Subjects With Pulmonary Arterial Hypertension (PAH) To Assess Long-Term Safety

NCT00796510 ·Status: TERMINATED ·Phase: PHASE3

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess Safety and Efficacy of Ambrisentan in Subjects With Pulmonary Arterial Hypertension.

NCT00423202 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of the Pharmacodynamic Effect of the Combination of Sildenafil and Riociguat on Blood Pressure and Other Safety Parameters.

NCT01179334 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Oral Bosentan in Pulmonary Arterial Hypertension Class II

NCT00091715 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Bosentan in Sickle Cell Disease (SCD) Patients Diagnosed With Pulmonary Hypertension (PH)

NCT00313196 ·Status: TERMINATED ·Phase: PHASE3

Role of Endothelin-A (ETA) and Endothelin-B (ETB) Receptors in the Vasodilatory Response to Endothelin-3 (ET-3)

NCT01100736 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Vardenafil Inhaled for Pulmonary Arterial Hypertension PRN Phase 2B Study

NCT04266197 ·Status: COMPLETED ·Phase: PHASE2

Long-Term Open-Label, Safety Study Of Sitaxentan Sodium In Japanese Pulmonary Arterial Hypertension Patients

NCT01210443 ·Status: TERMINATED ·Phase: PHASE3

A 12 Week Safety And Efficacy Study Of Sitaxentan Sodium In Japanese Pulmonary Arterial Hypertension Patients

NCT01204853 ·Status: TERMINATED ·Phase: PHASE3

A Study to Find Out if Selexipag is Effective and Safe in Patients With Chronic Thromboembolic Pulmonary Hypertension When the Disease is Inoperable or Persistent/Recurrent After Surgery and/or Interventional Treatment

NCT03689244 ·Status: TERMINATED ·Phase: PHASE3

First-line Bosentan and Sildenafil Combination Therapy for Pulmonary Arterial Hypertension

NCT01247116 ·Status: COMPLETED

Bosentan Effects in Inoperable Forms of Chronic Thromboembolic Pulmonary Hypertension

NCT00313222 ·Status: COMPLETED ·Phase: PHASE3

Efficacy, Safety, Tolerability and Pharmacokinetics (PK) of Nilotinib (AMN107) in Pulmonary Arterial Hypertension (PAH)

NCT01179737 ·Status: TERMINATED ·Phase: PHASE2

Clinical Study of Pulsed, Inhaled Nitric Oxide Versus Placebo in Symptomatic Subjects With PAH

NCT02725372 ·Status: TERMINATED ·Phase: PHASE3

Dose Determination Safety and Activity Study of Inhaled NX1011 to Treat Pulmonary Arterial Hypertension

NCT00323024 ·Status: WITHDRAWN ·Phase: PHASE2

A Dose Escalation Study to Evaluate the Effect of RT234 in Subjects With Pulmonary Arterial Hypertension

NCT05343637 ·Status: COMPLETED ·Phase: PHASE2

TEPH: Telaglenastat Efficacy in Pulmonary Hypertension

NCT07223528 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2

Safety and Efficacy of Inhaled Treprostinil in Patients With PAH

NCT01557647 ·Status: WITHDRAWN ·Phase: PHASE3

CXA-10 Study in Subjects With Pulmonary Arterial Hypertension

NCT04053543 ·Status: TERMINATED ·Phase: PHASE2